Skip to main content
Premium Trial:

Request an Annual Quote

Eurofins Genomics Extremers

Eurofins Genomics has launched its Extremer line of "extremely long" oligonucleotides in the US.

The company developed the oligos on its new DNA synthesis platform using high-fidelity chemistry for synthetic biology, next-generation DNA sequencing, and other applications.

Specific uses might include constructing genes with low sequence variability segments; templating in vitro transcription of RNA molecules; introducing large-scale or multi-site mutations; and generating oligos for DNA-directed RNA interference, capture probes, or qPCR control standards.

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.